Artículos por temáticas

Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind

Ağagündüz D, Kocaadam-Bozkurt B, Bozkurt O, Sharma H, Esposito R, Özoğul F, Capasso R.

Biomed Pharmacother. 2022 Sep;153:113430. doi: 10.1016/j.biopha.2022.113430. Epub 2022 Jul 18.

Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence

Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nisticò R.

Pharmacol Res. 2022 Oct;184:106404. doi: 10.1016/j.phrs.2022.106404. Epub 2022 Aug 18.

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium

Sexton C, Solis M, Aharon-Peretz J, Alexopoulos P, Apostolova LG, Bayen E, Birkenhager B, Cappa S, Constantinidou F, Fortea J, Gerritsen DL, Hassanin HI, Ibanez A, Ioannidis P, Karageorgiou E, Korczyn

Alzheimers Dement. 2022 Oct;18(10):1957-1968. doi: 10.1002/alz.12588. Epub 2022 Feb 20.

Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach

Tripathi P, Shukla P, Bieberich E.

Curr Pharm Des. 2022;28(2):116-132. doi: 10.2174/1381612827666211122153946.

Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease

Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V.

Bioorg Med Chem. 2022 May 1;61:116742. doi: 10.1016/j.bmc.2022.116742. Epub 2022 Apr 5.

Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review)

Bashir S, Uzair M, Abualait T, Arshad M, Khallaf RA, Niaz A, Thani Z, Yoo WK, Túnez I, Demirtas-Tatlidede A, Meo SA.

Mol Med Rep. 2022 Apr;25(4):109. doi: 10.3892/mmr.2022.12625. Epub 2022 Feb 4.

Effectiveness and safety of anti-tau drugs for Alzheimer's disease: Systematic review and meta-analysis

Zheng X, Tang Y, Yang Q, Wang S, Chen R, Tao C, Zhang P, Fan B, Zhan J, Tang C, Lu L.

J Am Geriatr Soc. 2022 Nov;70(11):3281-3292. doi: 10.1111/jgs.18025. Epub 2022 Oct 8.

Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review

Batool Z, Chen JH, Gao Y, Lu LW, Xu H, Liu B, Wang M, Chen F.

J Agric Food Chem. 2022 Dec 21;70(50):15631-15646. doi: 10.1021/acs.jafc.2c06206. Epub 2022 Dec 8.

Pivotal role of nitrogen heterocycles in Alzheimer's disease drug discovery

Kumari S, Maddeboina K, Bachu RD, Boddu SHS, Trippier PC, Tiwari AK.

Drug Discov Today. 2022 Oct;27(10):103322. doi: 10.1016/j.drudis.2022.07.007. Epub 2022 Jul 19.

Kaempferol as a potential neuroprotector in Alzheimer's disease

Nejabati HR, Roshangar L.

J Food Biochem. 2022 Dec;46(12):e14375. doi: 10.1111/jfbc.14375. Epub 2022 Aug 5.

Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage

Jiang YH, He JK, Li R, Chen ZH, Jia BH.

Chin J Integr Med. 2022 Mar;28(3):272-280. doi: 10.1007/s11655-022-3511-6. Epub 2022 Mar 1.

Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target

Gutiérrez IL, Dello Russo C, Novellino F, Caso JR, García-Bueno B, Leza JC, Madrigal JLM.

Int J Mol Sci. 2022 May 30;23(11):6143. doi: 10.3390/ijms23116143.

Association between urate-lowering therapies and cognitive decline in community-dwelling older adults

Molet-Benhamou L, Giudici KV, de Souto Barreto P, Cantet C, Rolland Y; MAPT/DSA group.

Sci Rep. 2022 Sep 12;12(1):15299. doi: 10.1038/s41598-022-17808-6.

Enhancing autophagy in Alzheimer's disease through drug repositioning

Eshraghi M, Ahmadi M, Afshar S, Lorzadeh S, Adlimoghaddam A, Rezvani Jalal N, West R, Dastghaib S, Igder S, Torshizi SRN, Mahmoodzadeh A, Mokarram P, Madrakian T, Albensi BC, Łos MJ, Ghavami S, Pecic

Pharmacol Ther. 2022 Sep;237:108171. doi: 10.1016/j.pharmthera.2022.108171. Epub 2022 Mar 16.

AD and its comorbidities: An obstacle to develop a clinically efficient treatment?

Baker J, Schott JM.

Rev Neurol (Paris). 2022 May;178(5):450-459. doi: 10.1016/j.neurol.2022.03.001. Epub 2022 May 2.